(Reuters) – Chinese authorities on Tuesday extended a lockdown in Shanghai to cover all of the financial hub’s 26 million people, despite growing anger over quarantine rules in the city, where latest results show only 268 daily symptomatic cases of COVID-19.
DEATHS AND INFECTIONS
*Eikon users, see COVID-19: MacroVitals https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1592404098 for case tracking and news summary.
* Greece will offer a second COVID-19 booster dose to people aged 60 and over, at least four months after the previous vaccine, Greek health authorities announced on Tuesday.
* President Joe Biden on Tuesday announced a national action plan to be developed by the U.S. Department of Health to deal with the looming health crisis of Long COVID, a complex disease with multiple symptoms that keeps many sick from working.
* U.S. Senate Republican Leader Mitch McConnell said on Tuesday that Democrats will have to accept a vote on an amendment to preserve Trump-era pandemic-related immigration restrictions in return for Republican support for a package $10 billion in COVID-19 spending.
* Quebec will require masks to be worn in indoor public spaces throughout April, delaying a plan to relax the measure until mid-month as it and other Canadian provinces grapple to a new wave of COVID-19, a senior public health official said Tuesday.
* COVAX, the global COVID-19 vaccine sharing project, and the African Union have declined options to purchase additional doses of Moderna’s vaccine, as developing countries struggle to allocate supplies.
* Most POSCO employees in South Korea returned to their offices from April 1, a spokesman for the steelmaker said on Tuesday, making it one of the first major companies in the country to implement back-to-office plans.
* The US health regulator said on Tuesday that antibody therapy from GlaxoSmithKline and Vir Biotechnology was no longer authorized to treat COVID-19 in the United States due to an increase in the proportion of cases caused by undercurrents. -Omicron variant.
* Two drugs that appeared to be promising treatments for COVID-19 in preliminary studies – remdesivir for hospitalized patients and camostat for patients who are not seriously ill – did not show benefit in these groups when tested. randomized controlled trials, the researchers reported in two separate articles.
* Oil prices stabilized in volatile trade on Tuesday as growing concerns that new coronavirus cases could dampen demand offset supply problems after the United States and Europe forecast to impose a new sanction on Russia for alleged war crimes in Ukraine.
* Japan’s service-sector activity fell for a third straight month in March as the coronavirus pandemic weighed on demand, while the Russia-Ukraine war cast doubts on the outlook.
* South Korea’s consumer prices rose at their fastest pace in more than a decade in March, fueled by rising energy and commodity costs from the Ukraine crisis and pressure further on the central bank ahead of its rate decision meeting next week.
* Growth in Ireland’s services sector accelerated in March to the fastest pace in five months despite inflationary pressures and growing uncertainty over Russia’s invasion of Ukraine, according to a survey released on Tuesday.
* Japanese household spending rose for a second straight month-on-year in February, helped by a flattering comparison to last year’s pandemic-induced sharp drop, but the consumer sector is now facing headwinds increasing opposites due to soaring prices.
(Compiled by Sherry Jacob-Phillips and Shinjini Ganguli; Editing by Arun Koyyur and Maju Samuel)